CAPERE Thrombectomy System Post-Market Clinical Follow Up Study

Stopped early

Conditions studied: Observational Study

In brief

A prospective, single-arm, non-blinded study, intending to collect and evaluate data in up to forty (40) human subjects with acute thrombosis, treated with the CAPERE™ Thrombectomy System.

Key facts

Study ID

NCT03869645

Run by

Medtronic Endovascular

People needed

18

Starts

2019-06-01

Expected to finish

2020-08-26

Last updated by the study team

2022-09-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who are greater than or equal to 18 years of age
• Patients with clinical signs, symptoms and presentation consistent with acute thrombosis; onset of symptoms < 14 days
• Patients cleared medically for invasive endovenous procedures

You may not qualify if…

• Patients with IVC filter in area to be treated
• Patients who are < 18 years of age.
• Known anaphylactic reaction of radiographic contrast agents that cannot be pre- treated
• Imaging evidence or other evidence that suggests the participant is not appropriate for mechanical thrombectomy intervention
• Female who is pregnant or nursing
• Concurrent participation in another investigational drug or device treatment study

Where it is running

• Memorial Health Services — Fountain Valley, California, United States
• St. Joseph Hospital — Orange, California, United States
• University of Virginia — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.